Migrena klinikiniai tyrimai Minesota
7 tyrimai dėl Migrena ieško dalyvių vietose Minesota.
Miestai Minesota
Oficialus tyrimo tekstas (anglų kalba)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Clinical Research Institute, Minneapolis
Renkami dalyviai1 fazė
Amžius nuo 6 iki 11 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Research Institute, Minneapolis
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-28 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Brackenridge Outpatient Research Pharmacy, Rochester
- Clinical Research Trials Unit, Rochester
- Mayo Clinic, Rochester
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Mayo Clinic, Rochester
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Minneapolis Clinic of Neurology - Burnsville /ID# 232551, Burnsville
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Clinical Research Institute, Minneapolis
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli
- University of Minnesota, Minneapolis
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-01-14 · NCT06961864Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.